Embarc

Larkspur Health Acquisition Corp.

Merged
CIK: 1859007•Ticker: LSPR•Merged Ticker: ZVSA
Successfully merged with ZyVersa Therapeutics • Now trading as ZVSA

SPAC Overview

$75M
IPO Size
Completed
Current Status
2021
IPO Year

Timeline Progress

Investment Focus

Biotech

SPAC Team

Sponsors

Larkspur HealthM2B Funding CorporationApollo Management GroupAlpha Capital AnstaltRange VenturesFrancis Knuettel IINicholas KovacevichThomas Poletti

Leadership

Daniel J. O’Connor
Chairman, Chief Executive Officer, and Director
David S. Briones
Chief Financial Officer and Treasurer, and Director
Raj Mehra, Ph.D., J.D.
Director
Gregory Skalicky
Director
Christopher Twitty, Ph.D.
Director
Raj Mehra, Ph.D., J.D.
Director

Stock Performance

ZVSA
Trading Symbol
First Trade
February 14, 2022
$3,444.00
At Merger
December 16, 2022
$1,127.00
-67%
6 Months Post-Merger
June 20, 2023
$101.89
-91%
1 Year Post-Merger
December 18, 2023
$10.70
-99%
2 Years Post-Merger
December 16, 2024
$1.03
-100%
Current Price
May 30, 2025
$0.63
-100%

Key Information

December 22, 2021
December 15, 2022
ZyVersa Therapeutics
LSPRU
ZVSA

External Resources

SEC Filings
View Detailed Analysis